dihexa cancer risk hgf c met The HGF/c-Met Axis: A Promising Therapeutic Target in Dihexa (PNB-0408) | c-Met/HGFR Activator
Dihexa (PNB 0408) c Met HGFR Activator MedChemExpress dihexa c met cancer risk Developing pathway inhibitors for therapy: progress and challenges: Trends in Molecular Medicine Activated HGF c Met Axis in Head Correlation between hypoxia and HGF c MET expression in the management of pancreatic cancer ScienceDirect Frontiers Hepatocyte growth factor mimetic protects lateral line hair cells from aminoglycoside exposure
Pay in 4 interest-free payments of $5.14 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



